Here is one of our April 22, 2018 Medical Laboratory Professionals Week case studies for your response. Watch for more "Lab Week" case studies in the weeks ahead!
May 24, 2018 12:15pm
May 24, 2018 12:01pm
On May 4, the FDA approved andexanet alpha (AndexXa, Portola Pharmaceuticsls) as the first and only reversal agent for direct anti-Xa
May 11, 2018 1:25pm
From Heather DeVries, Indiana University Health, a follow-up to Dr. King's April 26 pseudothrombocytopenia entry: Hi George, I recently read an article by Drs. Adcock Funk, Lippi, and Favaloro about quality standards in coagulation testing.